Blueberries Medical Corp. (BBRRF)
OTCMKTS
· Delayed Price · Currency is USD
0.0100
+0.0001 (1.01%)
May 5, 2025, 2:27 PM EDT
Blueberries Medical Revenue
In the year 2024, Blueberries Medical had annual revenue of 471.41K CAD with 63.53% growth. Blueberries Medical had revenue of 265.27K in the quarter ending December 31, 2024, with 344.60% growth.
Revenue
471.41K CAD
Revenue Growth
+63.53%
P/S Ratio
10.95
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.59M USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Tian'an Technology Group | 1.78M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
Blueberries Medical News
- 5 weeks ago - Blueberries Medical Announces C$1 Million Non-Brokered Private Placement - GlobeNewsWire
- 2 months ago - Blueberries Medical Announces C$1 Million Non-Brokered Private Placement - GlobeNewsWire
- 1 year ago - Blueberries Medical Announces Closing of C$2 Million Non-Brokered Private Placement - GlobeNewsWire
- 1 year ago - Blueberries Medical Announces C$2 Million Non-Brokered Private Placement - GlobeNewsWire
- 2 years ago - Blueberries Medical Reports Q1-2023 - GlobeNewsWire
- 2 years ago - Blueberries Medical Reports 2022 Financial Results - GlobeNewsWire
- 2 years ago - Blueberries Medical Announces Closing of US$1.1 Million Non-Brokered Private Placement, reports 2022 Q3 Financial Results and provides Corporate and Operations Update - GlobeNewsWire
- 2 years ago - Blueberries Medical Reports 2022 Q2 Financial Results and Provides Corporate and Operations Update - GlobeNewsWire